Top stories
An online survey on a global research agenda on public health and social measures during health emergencies
25 August 2022 Call for dataWHO invites the global stakeholders working across various sectors, at different levels and in various roles to participate in a brief survey to contribute to the development of a global research agenda for public health and social measures (PHSM) during health emergencies.Click here to access the surveyThe survey takes about 10 minutes to complete and seeks to identify immediate and urgent PHSM research priorities related to COVID-19 in the next 12 months. Six research themes and 45 priority research questions and topics in this survey were previously discussed during the first WHO global technical consultation on PHSM held from 31 August to 2 September 2021. This public survey, therefore, serves as the second stage of verification to improve the appropriateness and relevance of these proposed research questions.
PHSM are part of critical interventions during health emergencies to reduce the transmission of pathogens with epidemic and pandemic potential. PHSM refer to actions including non-pharmaceutical interventions which reduce physical contacts or make them safer. They contribute to lowering transmission, hospitalization rates and deaths, hence reduce the pressure on the health care system enabling it to maintain essential health services, buy time to develop and implement pharmaceutical interventions, and offer increased individual and community protection. WHO’s multi-year PHSM initiative in the High Impact Events Preparedness (IEP) unit in the Department of Epidemic and Pandemic Preparedness and Prevention (EPP) aims to accelerate global research and strengthen precision in PHSM policies and implementation. Towards understanding the effectiveness as well as health, social and economic impact of PHSM during health emergencies, this public survey informs the development of the global research agenda 2021-2030 covering immediate (next 12 months) and medium- to long-term (after 12 months and up to the end of 2030) priorities. This survey focuses first on the immediate priorities.
The survey is voluntary. It is anonymous and does not collect any personal information or contact details of the respondents. Only aggregate information will be analysed. Following a consultation and verification with PHSM working groups, the result of the survey will be published on the WHO website.
The survey will close on 30 September 2022. If you have further questions about the survey, you can contact phsm@who.int
Source: WHO website
The Democratic Republic of the Congo declares Ebola resurgence in North Kivu
Brazzaville/Kinshasa – Health authorities in the Democratic Republic of the Congo declared a resurgence of Ebola late last night, following confirmation of one case in the country’s eastern province of North Kivu.
A 46-year-old woman died on 15 August 2022 in Beni, a town located in North Kivu. She received care at the Beni Referral Hospital, initially for other ailments, but subsequently exhibited symptoms consistent with Ebola virus disease
Both the Beni and Goma branches of the country’s National Institute of Biomedical Research (INRB) confirmed Ebola virus in samples taken from the patient. Analyses showed that the case was genetically linked to the 2018-2020 Ebola outbreak in North Kivu and Ituri Provinces—the country’s longest and largest.
“Ebola resurgences are occurring with greater frequency in the Democratic Republic of the Congo which is concerning. However, health authorities in North Kivu have successfully stopped several Ebola flare-ups and building on this expertise will no doubt bring this one under control quickly,” said Dr Matshidiso Moeti, World Health Organization (WHO) Regional Director for Africa.
WHO staff and health authorities in the Democratic Republic of Congo working to stem the spread of the disease, having identified 160 contacts whose health is being closely monitored. Investigations are ongoing to determine the vaccination status of the confirmed case.
There are 1000 doses of the rVSV-ZEBOV Ebola vaccines available in the country’s stockpile, 200 of which will be sent to Beni this week. Ring-vaccination—where contacts and contacts of contacts are vaccinated to curb the spread of the virus and protect lives—is expected to begin shortly.
The last flare-up in North Kivu’s Beni health zone was brought under control in about two months, ending on 16 December 2021. There were 11 cases (eight confirmed, three probable), including six deaths.
Source: for more information please visit the WHO AFRO website.
The Democratic Republic of the Congo declares 14th Ebola outbreak over
Brazzaville/Kinshasa – The Democratic Republic of the Congo today declared the end of the Ebola outbreak that erupted less than three months ago in Mbandaka, the capital of Equateur Province in the northwest. It was the third outbreak in the province since 2018 and the country’s 14th overall.
With greater experience in Ebola control, national emergency teams, with the support from World Health Organization (WHO) and partners, mounted a swift response soon after the outbreak was declared on 23 April, rolling out key counter measures including testing, contact tracing, infection prevention and control, treatmentand community engagement. Vaccination – a crucial protective measure – was launched just four days after the outbreak was declared.
In all, there were four confirmed cases and one probable case – all of whom died. In the previous outbreak in Equateur Province that lasted from June to November 2020, there were 130 confirmed cases and 55 deaths.
“Thanks to the robust response by the national authorities, this outbreak has been brought to an end swiftly withlimited transmission of the virus,” said Dr Matshidiso Moeti, WHO Regional Director for Africa. “Crucial lessons have been learned from past outbreaks and they have been applied to devise and deploy an ever more effective Ebola response.”
The just ended outbreak saw a total of 2104 people vaccinated, including 302 contacts and 1307 frontline workers. To facilitate the vaccination rollout, an ultra-cold chain freezer was installed in Mbandaka which allowed for vaccine doses to be stored locally and safely and be delivered effectively.
The Democratic Republic of the Congo has now recorded 14 Ebola outbreaks since 1976, six of which have occurred since 2018.
“Africa is seeing an increase in Ebola and other infectious diseases that jump from animals to humans impacting large urban areas,” said Dr Moeti. “We need to be ever more vigilant to ensure we catch cases quickly. This outbreak response shows that by bolstering preparedness, disease surveillance and swift detection, we can stay a step ahead.”
WHO supported the Democratic Republic of the Congo in implementing a strong national strategy developed early to guide response coordination; decentralizing operations to the lowest level to work closely with communities; basing the response on evidence; and regularly analysing the epidemiological risk to rapidly adjust the response.
Although the outbreak in Mbandaka has been declared over, health authorities are maintaining surveillance and are ready to respond quickly to any flare-ups. It is not unusual for sporadic cases to occur following an outbreak.
The disease, which affects humans and other primates, is severe and often fatal. Case fatality rates have varied from 25% to 90% in past outbreaks. However, with the currently available effective treatment, patients have a significantly higher chance of survival if they are treated early and given supportive care.
Source: WHO AFRO
Integrated Outbreak Analytics delivers holistic understanding of outbreak dynamics
30 April 2022 I Geneva - The seeds for Integrated Outbreak Analytics (IOA) were sown during the 2018 Ebola response in eastern Democratic Republic of Congo (DRC) as the social science and epidemiology cells worked collaboratively to deliver real time systematic operational research to inform evidence-based response. In 2020, IOA was formalised as a GOARN working group to establish a platform for exchange for all partners in the GOARN network. Since then, IOA has operated as a multi-disciplinary approach to understanding outbreak dynamics in many different outbreaks including plague and cholera and to inform outbreak response with multiple partners. Today, IOA aims to drive comprehensive, accountable, and effective public health and clinical strategies by enabling communities, and national and subnational health authorities to use data for operational decision-making. IOA embraces a holistic perspective of outbreak dynamics throughout: from the research questions to the data that are collected or accessed, to the interpretation of results and the recommendations that follow. In addition, IOA promotes co-development and monitoring of evidence-informed recommendations with Ministries of Health. The quarterly IOA Field Exchange shares IOA initiatives and experiences from across the world, at different levels, to facilitate dialogue between and learning opportunities for individuals and organisations working in IOA. It aims to highlight the benefits of IOA to public health emergency response and evidence-based decision-making but also to discuss the realities of IOA in practice, the challenges and the lessons-learned. IOA will always vary context to context and we respect and encourage that diversity.
New fund for pandemic prevention, preparedness and response formally established
9 September 2022 I Geneva
The new financial intermediary fund (FIF) for pandemic prevention, preparedness, and response (PPR) was officially established by the FIF Governing Board at its inaugural meeting from 8-9 September 2022.
The fund will provide a dedicated stream of additional, long-term financing to strengthen PPR capabilities in low- and middle-income countries and address critical gaps through investments and technical support at the national, regional, and global levels. The fund will draw on the strengths and comparative advantages of key institutions engaged in PPR, provide complementary support, improve coordination among partners, incentivize increased country investments, serve as a platform for advocacy, and help focus and sustain much-needed, high-level attention on strengthening health systems.
The first calls for proposals for investments to be funded by the FIF will open in November 2022.
“COVID-19 has highlighted the pressing need for action to build stronger health systems,” said World Bank Group President David Malpass. “Investing now will save lives and resources for the years to come. We welcome the broad support from the international community for this new, multilateral financial intermediary fund at the World Bank to help low- and middle-income countries and regions become better prepared for global health crises and are pleased to have been able to proceed quickly in establishing the fund.”
The fund’s establishment follows approval by the World Bank’s Board of Directors on June 30, 2022. The World Bank will serve as the FIF’s trustee and host the Secretariat, which will include technical staff seconded from the World Health Organization (WHO). The Governing Board will appoint a Technical Advisory Panel, chaired by WHO, and comprising leading experts to assess and make recommendations to the Governing Board on the technical merits of proposals for funding, ensuring linkages to the International Health Regulations, as part of the broader global PPR architecture.
“The COVID-19 pandemic has been a seismic shock to the world, but we also know that the next pandemic is a matter of when, not if,” said WHO Director-General, Dr Tedros Adhanom Ghebreyesus. "The suffering and loss we have all endured will be in vain unless we learn the painful lessons from COVID-19 and put in place the measures to fill critical gaps in the world’s defences against epidemics and pandemics. The FIF is one of those key measures, and WHO looks forward to fulfilling its technical leadership role in advising the FIF Board on where to make the most effective investments to protect health, especially in low- and middle-income countries.”
The new fund is overseen by a Governing Board, which will set the overall work program and make funding decisions. The FIF’s Governing Board includes equal representation of sovereign donors and potential implementing country governments (co-investors), as well as representatives from foundations and civil society organizations (CSOs).
The World Bank and WHO will intensify their work with the Governing Board in consultation with CSOs and other stakeholders, to help operationalize the fund and develop the FIF results framework and priorities in the run up to the first call for proposals.
FIF financing could help strengthen and sustain PPR capacity in areas such as zoonotic disease surveillance; laboratories; emergency communication, coordination and management; critical health workforce capacities; and community engagement. FIF-financed projects can also help strengthen PPR at the regional and global levels, for example, by building capacity for medical countermeasures. The FIF can support peer-to-peer learning, provide targeted technical assistance, and help with the systematic monitoring of PPR capacities.
The FIF was developed with broad support from members of the G20 and beyond. Over US$1.4 billion in financial commitments have already been announced and more are expected in the coming months. So far, commitments have been made by Australia, Canada, China, the European Commission, France, Germany, India, Indonesia, Italy, Japan, Republic of Korea, New Zealand, Norway, Singapore, South Africa, Spain, the United Arab Emirates, the United Kingdom, the United States, the Bill & Melinda Gates Foundation, the Rockefeller Foundation, and Wellcome Trust.
Source: WHO website
Updates
Take a look around our recent updates
watchlist
Webinar on operational research developments and activities in SEAR - 17th May, 15h00 IST
Communications and community engagement interim guidance on using inclusive language in understanding, preventing and addressing stigma and discrimination related to monkeypox
Call for submissions : Good practices on COVID-19 Youth Engagement and Youth Leadership. Deadline 22 July 2022
About us
Ultimate experiences with story, emotion and purpose
About GOARN
We are a WHO network of over 250 technical institutions and networks globally that respond to acute public health events with the deployment of staff and resources to affected countries. Coordinated by an Operational Support Team based at the WHO headquarters in Geneva and governed by a Steering committee, we aim to deliver rapid and effective support to prevent and control infectious diseases outbreaks and public health emergencies when requested.
The GOARN Operational support team (OST) is based at the World health Organization in Geneva, Switzerland and in various WHO Regional Offices supporting outbreak response at the regional level. The OST facilitates the day to day running of the network and coordinates outbreak response missions, network activities and communications for the Network.
You can reach the Operational support team for more information on how to get involved with GOARN.
The Steering Committee (SCOM) of the Global outbreak alert and response network (GOARN) is a representative body of 21 partner institutions that oversee the planning, implementation and evaluation of the Network activities and strategic goals.
The Committee fulfills the following functions:
- approving and monitoring the implementation of the Network’s work plan;
- approving the terms of reference and monitoring the activities of Technical Working Groups and Standing Sub-Committees;
- approving the addition of new institutions/organizations/networks to the Network.
- advocating for the network and representing the network at key public health events.
Partner institutions
Africa Centers for Disease Control and Prevention
African Coalition for Epidemic Research, Response and Training (ALERRT)
African Field Epidemiology Network (AFENET)
Aix-Marseille University
American University of Beirut Medical Center
Amref Health Africa
Animal and Plant Health Agency (APHA)
APEC Emerging Infections Network (EINET)
ARM Network (Australian Response MAE Network)
Armed Forces Health Surveillance Branch (AFHSB)
Armed Forces Research Institute for Medical Sciences (AFRIMS)
Association of Asia Pacific Operational Research Societies (APORS)
Association of Medical Doctors of Asia (AMDA)
Association of Public Health Laboratories (APHL)
Association pour le développement de l’épidémiologie de terrain (EPITER)
Australasian College for Infection Prevention and Control (ACIPC), formerly AICA
Australian National Centre for Immunisation Research and Surveillance (NCIRS)
Bernhard Nocht Institute for Tropical Medicine
Bundeswehr Institute of Microbiology
Bureau of Epidemiology, Surveillance and Response Unit, Ministry of Health Thailand
Burnet Institute for Medical Research and Public Health
Cambridge Infectious Diseases
Caribbean Public Health Agency (CARPHA)
CDC Egypt Country Office- NAMRU-3
Center for Communicable Diseases Control (CDC) Iran, Ministry of Health and Medical Education (MOH&ME)
Center for Emerging Viral Diseases, HUG
Center for Infection and Immunity, Mailman School of Public Health of Columbia University
Center for Infectious Diseases, Nara Medical University
Centers for Disease Control and Prevention (CDC)
Central Department of Microbiology, Tribhuvan University
Centre d’épidémiologie et de santé publique des armées (CESPA)
Centre for Applied Molecular Technologies (CTMA)
Centre for Health Crises, Karolinska Institutet
Centre for Health Protection (CHP), Department of Health
Centre International de Recherches Médicales de Franceville (CIRMF)
Centre National de Transfusion Sanguine (CNTS) - Burkina Faso
Centro Nacional de Epidemiología, Ministerio de Salud Pública y Asistencia Social, Guatemala
Chan Zuckerberg Biohub
Charité University Clinics
Chinese Center for Disease Control and Prevention, (China CDC)
Cho Ray hospital (CRH)
Clinical Research Unit, Hospital for Tropical Diseases
Collaborative for the Advancement of Infection Prevention and Control (CAIPC)
College of Public Health, Medical and Veterinary Sciences, James Cook University
CSIRO Australian Animal Health Laboratory
Dengue Unit, Queen Sirikit National Institute of Child Health (QSNICH)
Department of Public Health, Osaka Metropolitan University Graduate School of Medicine
Department of Virology, Tohoku University, School of Medicine
Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH - SEEG
Dirección General de Epidemiología, Subsecretaría de Prevención y Promoción de la Salud, Secretaría de Salud, México
Direction of Epidemiology and Health Information, Ministry of Health Djibouti
Directorate General for Disease Surveillance and Control, Ministry of Health Oman
Directory of Epidemiology and Control Diseases (DELM) /MOH Morocco
Division des laboratoires - Ministère de la Santé et de la Protection Sociale
Division of Tuberculosis and Infectious Disease Control, Ministry of Health, Labour and Welfare
Doctors Without Borders - Australia (MSF)
Doherty Institute
East African Integrated Disease Surveillance (EAIDSNet), National Institute for Medical Research (NIMR)
Eastern Mediterranean Public Health Network (EMPHNET)
Emergency Medical Teams
Emory Eye Center
Empower School of Health
EPICENTRE
Epidemic Surveillance and Response Division, Rwanda Biomedical Centre
Epidemiology Bureau, Department of Health, Philippines
Epidemiology Intelligence Program (EIP), Malaysia
EPIET Alumni Network (EAN)
Erasmus MC
Etablissement de Préparation et de Réponse aux Urgences Sanitaires (EPRUS)
European Centre for Disease Prevention and Control (ECDC)
European Mobile Laboratory (EMLab)
European Programme for Intervention Epidemiology Training (EPIET)
European Virus Archive goes Global (EVAg)
Faculty of Health Sciences, Curtin University of Technology
Faculty of Medicine, Chulalongkorn University
Faculty of Public Health - Lebanese University
Federal Public Service - Health, Food Chain Safety and Environment (FPS)
Federal University Oye Ekiti
Field Epidemiology Training Programme – Papua New Guinea (FETP- PNG)
FIND
Friedrich-Loeffler-Institut – Federal Research Institute for Animal Health (FLI)
German Armed Forces Medical Service, GER Ministry of Defence
Global Virus Network
GOARN Secretariat
Guangdong Provincial Center for Disease Control and Prevention
Harvard Humanitarian Initiative (HHI)
Health Emergency Operation Center (HEOC) , Nepal
Health Intervention and Technology Assessment Program (HITAP)
Health Protection Surveillance Centre (HPSC)
Hokkaido University Research Center for Zoonosis Control
Hunter New England Health
Indonesia Epidemiological Association (IEA-PAEI)
Indonesia PHEOC / FETP
Indo-Pacific Centre for Health Security, Department of Foreign Affairs and Trade
Infection Control Africa Network (ICAN)
Infectious Diseases Data Observatory (IDDO)
Inserm - European Union West Africa Mobile Lab (EUWAM Lab)
Inserm - REACTing
Institut fuer Virologie, Philipps-Universität Marburg
Institut National de Recherche Biomédicale (INRB)
Institut National d'Hygiène
Institut Pasteur (IP), Algeria
Institut Pasteur (IP), Bangui
Institut Pasteur (IP), Cambodia
Institut Pasteur (IP), Cote d'Ivoire
Institut Pasteur (IP), Dakar
Institut Pasteur (IP), Guyane
Institut Pasteur (IP), International
Institut Pasteur (IP), Lyon
Institut Pasteur (IP), Morocco
Institut Pasteur (IP), Nouvelle-Calédonie
Institut Pasteur (IP), Tunis
Institut Pasteur of Shanghai, Chinese Academy of Sciences
Institute de Recherche pour le Developpement (IRD)
Institute for Glycomics - Griffith University, Gold Coast Campus, Queensland
Institute of Environmental Science and Research Limited (ESR)
Institute of Epidemiology, Disease Control and Research (IEDCR)
Institute of Health and Community Medicine (IHCM) Universiti Malaysia Sarawak
Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana
Institute of Tropical Medicine (ITM)
Institute of Tropical Medicine, Nagasaki University
Institute of Virology, Biomedical Research Center, Slovak Academy of Sciences
Institute of Virology, Charité Berlin
Institute Pasteur (IP), Iran
Instituto de Salud Carlos III (ISCIII)
Instituto Evandro Chagas (IEC)
Instituto Nacional de Enfermedades Virales Humanas J.MAIZTEGUI (INEVH)
Instituto Nacional de Salud (NIH Peru)
International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)
International Committee of the Red Cross (ICRC)
International Council of Nurses (ICN)
International Epidemiological Association (IEA)
International Federation of Red Cross and Red Crescent Societies (IFRC)
International FETP, Thailand
International Organization for Migration (IOM)
International Rescue Committee (IRC)
International Severe Acute Respiratory and emerging Infection Consortium (ISARIC)
Israeli Medical Association (IMA)
Istituto Superiore di Sanita (ISS)
Japan Disaster Relief Team (JDR), Japan International Cooperation Agency (JICA)
Japanese Red Cross Wakayama Medical Center
Johanniter-Unfall-Hilfe e.V. Headquarters Berlin
Johns Hopkins University
Jordan Food and Drug Administration
JW LEE Center for Global Medicine, Seoul National University College of Medicine
Kenya Medical Research Institute (KEMRI)
King Abdulaziz Medical City, National Guard Health Affairs
KIT Royal Tropical Institute
Korea Disease Control and Prevention Agency (KDCA)
KU Leuven
Kurume University
Laboratory P4 Inserm Jean Merieux
Laval University
Liverpool School of Tropical Medicine
London School of Hygiene and Tropical Medicine (LSHTM)
Manipal Institute of Virology
Médecins Sans Frontières - Belgium (MSF Belgium)
Médecins Sans Frontières - France (MSF France)
Médecins Sans Frontières - Holland (MSF Holland)
Médecins Sans Frontières - International Office (MSF)
Médecins Sans Frontières - Spain (MSF Spain)
Medecins Sans Frontieres - Switzerland (MSF Switzerland)
Medical Mission Institute, Department of Tropical Medicine
Medical University of Vienna, Center for Public Health
Mediterranean and Black Sea Programme for Intervention Epidemiology Training (MediPIET)
Mekong Basin Disease Surveillance (MBDS)
Merieux Fondation
Mie National Hospital
Ministry of Health and Population, Central African Republic
Ministry of Health and Prevention United Arab Emirates, Emergency - Crisis - Disaster Operations Center
Ministry of Health Portugal, Office of the Director General of Health
Ministry of Health Sudan, National Public Health Laboratory (NPHL)
Ministry of Health, Consumers and Social Welfare, Spain
Ministry of Health, Singapore
Ministry of Public Health, Lebanon
MRC - University of Glasgow Centre for Virus Research
MRC Centre for Global Infectious Disease Analysis, Imperial College London
Museum national d histoire naturelle (MNHN)
mWater
National Agency for Public Health (NAPH), Moldova
National Center for Global Health and Medicine, Japan
National Centre for Disease Control (NCDC), India
National Centre for Epidemiology and Population Health (NCEPH), The Australian National University (ANU)
National Centre for Infectious Diseases (NCID)
National Critical Care and Trauma Response Centre (NCCTRC)
National Institute for Communicable Diseases (NICD), South Africa
National institute for Health and Welfare (THL)
National Institute for Infectious Diseases Lazzaro Spallanzani (INMI)
National Institute of Health - NIH Pakistan
National Institute of Health Dr Ricardo Jorge (NIH Portugal)
National Institute of High Security Animal Disease, Bhopal, India
National Institute of Hygiene and Epidemiology (NIHE)
National Institute of Infectious Diseases (NIID)
National Institute of Public Health - National Institute of Hygiene, Poland (PZH)
National Institute of Virology (NIV), India
National Public Health Laboratory, Nepal
National School of Public Health, Greece
National University of Ireland, Galway
National University of Singapore (NUS)
Naval Medical Research Unit, NAMRU-3
New England Complex Systems Institute (NECSI)
Nigeria Centre for Disease Control (NCDC)
Norwegian Armed Forces Medical Services
Norwegian Institute of Public Health (NIPH)
Norwegian National Unit for CBRNE Medicine at Oslo University Hospital
Office of Health Protection, Department of Health (DOHA)
One Health
One Health European Joint Programme (One Health EJP)
One Health Institute, University of California, Davis
Osaka University
Our Lady of Snow Medical Juridical Corporation St. Marys Hospital
Pacific Disaster Center (PDC)
Papua New Guinea Institute of Medical Research (PNG IMR)
Pasteur Institute in Ho Chi Minh City
Pasteur Institute in Nha Trang
PathWest Laboratory Medicine WA
Population Council Institute
Premiere Urgence Internationale (PUI)
ProEpi
Program in Emerging Infectious Diseases, Duke-NUS Graduate Medical School
ProMED
Public Health Agency of Canada (PHAC)
Public Health Agency of Sweden
RCCE Collective Service
Regional Center of Disease Surveillance and Control, WAHO
Reseau des Experts Sanitaires des Eaux (RESEaux)
Resolve to Save Lives
RIVM, National Institute for Public Health and the Environment
Robert Koch Institut (RKI)
Rospotrebnadzor
Samaritan’s Purse International
Santé publique France
Save the Children International
School of Medicine, Niigata University
School of Population Health, UNSW Medicine
Scientific Institute of Public Health Belgium
Secretariat of the Pacific Community (SPC)
Singapore General Hospital
South African Centre for Epidemiological Modelling and Analysis (SACEMA)
Spiez Laboratory, Federal Office for Civil Protection (FOCP)
Statens Serum Institut (SSI)
Stavropol Antiplague Research Institute
Sukra Raj Tropical and Infectious Disease Hospital
Swiss Humanitarian Aid Unit (SHA), Swiss Agency for Development and Cooperation (SDC)
Swiss Tropical and Public Health Institute
Tan Tock Seng Hospital
Tay Nguyen Institute of Hygiene and Epidemiology (TIHE), Vietnam
The Alliance for International Medical Action (ALIMA)
The Chinese University of Hong Kong
The INCLEN Trust International
The Koret School of Veterinary Medicine
The University of New South Wales, Sydney
The University of Newcastle (UON), Australia
The University of the West Indies
The University of Western Australia
Toshima Hospital
Training Programmes in Epidemiology and Public Health Interventions Network (TEPHINET)
Tulane School of Public Health and Tropical Medicine
U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID)
UK Health Security Agency (UKHSA)
UK Public Health Rapid Support Team
United Nations Childrens Fund (UNICEF)
United Nations Food and Agriculture Organization (FAO)
United Nations High Commission for Refugees (UNHCR)
Universidade Federal do Rio de Janeiro
University Hospital Düsseldorf
University of Geneva, Faculty of Medicine (HUG)
University of Hong Kong
University of Nebraska Medical Center (UNMC)
University of Sydney Institute for Infectious Diseases
University of Texas Medical Branch (UTMB)
University of Warwick
Westmead Hospital
WHO Department of Environment, Climate Change and Health
WHO Department of Food Safety, Zoonoses and Foodborne Diseases
WHO Emerging and Dangerous Pathogens Laboratory Network (EDPLN)
WHO EPI Essential Programme on Immunization
WHO Epidemic Diseases Clinical Assessment and Response Network (EDCARN)
WHO Global Infection Prevention and Control Network (GIPCN)
WHO Information Management and Technology
WHO Regional Office for Africa (AFRO)
WHO Regional Office for Europe (EURO)
WHO Regional Office for South-East Asia (SEARO)
WHO Regional Office for the Americas (AMRO)
WHO Regional Office for the Eastern Mediterranean (EMRO)
WHO Regional Office for the Western Pacific (WPRO)
WHO The International Food Safety Authorities Network (INFOSAN)
WHO Virtual Interdisciplinary Advisory Group on Mass Gathering
WHO WHE Country Health Emergency Preparedness & IHR (CPI)
WHO WHE Emergency Response (WRE)
WHO WHE Executive Director Office
WHO WHE Global Task Force on Cholera Control (GTFCC)
WHO WHE Health Emergency Information & Risk Assessment (HIM)
WHO WHE Infectious Hazard Management (IHM)
WHO WHE Management & Administration (MGA)
WHO WHE Operations Support and Logistics
World Health Organization Staff Health & Wellbeing Services (SHW)
World Organisation for Animal Health (OIE)
Institut Pasteur (IP), Algeria
AlgeriaInstituto Nacional de Enfermedades Virales Humanas J.MAIZTEGUI (INEVH)
ArgentinaFaculty of Health Sciences, Curtin University of Technology
AustraliaCSIRO Australian Animal Health Laboratory
AustraliaThe University of New South Wales, Sydney
AustraliaInstitute for Glycomics - Griffith University, Gold Coast Campus, Queensland
AustraliaARM Network (Australian Response MAE Network)
AustraliaOffice of Health Protection, Department of Health (DOHA)
AustraliaDoherty Institute
AustraliaAustralasian College for Infection Prevention and Control (ACIPC), formerly AICA
Australia
Burnet Institute for Medical Research and Public Health
AustraliaCollaborative for the Advancement of Infection Prevention and Control (CAIPC)
AustraliaSchool of Population Health, UNSW Medicine
AustraliaHunter New England Health
AustraliaThe University of Western Australia
AustraliaThe University of Newcastle (UON), Australia
AustraliaPathWest Laboratory Medicine WA
AustraliaAustralian National Centre for Immunisation Research and Surveillance (NCIRS)
AustraliaDoctors Without Borders - Australia (MSF)
AustraliaUniversity of Sydney Institute for Infectious Diseases
Australia
National Centre for Epidemiology and Population Health (NCEPH), The Australian National University (ANU)
AustraliaNational Critical Care and Trauma Response Centre (NCCTRC)
AustraliaWestmead Hospital
AustraliaIndo-Pacific Centre for Health Security, Department of Foreign Affairs and Trade
AustraliaCollege of Public Health, Medical and Veterinary Sciences, James Cook University
AustraliaMedical University of Vienna, Center for Public Health
AustriaInstitute of Epidemiology, Disease Control and Research (IEDCR)
BangladeshInternational Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)
BangladeshThe University of the West Indies
BarbadosInstitute of Tropical Medicine (ITM)
Belgium
What we do
Global Outbreak Alert and Response Network
GOARN STORIES
I love GOARN and work with GOARN
Takuya Adachi